Associations of Gadolinium-Based Contrast Agent Exposures With Physical and Cognitive Disability in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis
J Neuroimaging 2022 Oct 01;[EPub Ahead of Print], K Nakamura, MP McGinley, SE Jones, MJ Lowe, JA Cohen, PM Ruggieri, D OntanedaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.